Details of the Drug Formulation (DFM)
General Information of DFM (ID: F23917) | |||||
---|---|---|---|---|---|
Name |
Terconazole 80 mg Vaginal Suppository
|
||||
Company |
Janssen Pharms
|
||||
Active Pharmaceutical Ingredient (API) | Terconazole |
API Info
![]() |
|||
Approved | |||||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0QV6C | DIG Info | Butylhydroxyanisole | Antimicrobial preservative ... | ||
E0C3AX | DIG Info | Lauric acid | Antifoaming agent ... | ||
E0X2OX | DIG Info | Medium-chain triglyceride | Emollient ... | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
G-protein coupled receptor (GPCR) | ||||||
DBT Name: Free fatty acid receptor 1 (FFAR1) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | EC50 = 758.58 nM (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | FFAR1_HUMAN | |||||
DBT Name: Free fatty acid receptor 4 (FFAR4) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | EC50 = 7585.78 nM (tested by experiment) | [2] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | FFAR4_HUMAN | |||||
DBT Name: GPCR84 receptor (GPR84) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | Ki = 2170 nM (tested by experiment) | [3] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | GPR84_HUMAN | |||||
DBT Name: Muscarinic receptor M1 (ACM1) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Butylhydroxyanisole | |||||
Biological Activity | IC50 = 19 uM (tested by experiment) | [4] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ACM1_HUMAN | |||||
DBT Name: Alpha-1A adrenoceptor (ADA1A) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Butylhydroxyanisole | |||||
Biological Activity | IC50 = 19 uM (tested by experiment) | [4] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | ADA1A_HUMAN | |||||
Oxidoreductase (ORase) | ||||||
DBT Name: Prostaglandin G/H synthase 2 (COX-2) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Butylhydroxyanisole | |||||
Biological Activity | IC50 = 2.6 uM (tested by experiment) | [4] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PGH2_HUMAN | |||||
Nuclear receptor (NR) | ||||||
DBT Name: PPAR-alpha (PPARA) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | IC50 = 30000 nM (tested by experiment) | [5] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARA_HUMAN | |||||
DBT Name: PPAR-delta (PPARD) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | IC50 = 30000 nM (tested by experiment) | [5] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARD_HUMAN | |||||
DBT Name: PPAR-gamma (PPARG) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lauric acid | |||||
Biological Activity | IC50 = 30000 nM (tested by experiment) | [5] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PPARG_HUMAN | |||||
DBT Name: Progesterone receptor (PGR) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Butylhydroxyanisole | |||||
Biological Activity | IC50 = 29 uM (tested by experiment) | [4] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | PRGR_HUMAN | |||||
Cell line (CELL) | ||||||
DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
Detailed Information |
DBT Info
![]() |
|||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Medium-chain triglyceride | |||||
Biological Activity | Inhibition ratio > 36 % (tested by experiment) | [6] | ||||
Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.